nodes	percent_of_prediction	percent_of_DWPC	metapath
Tamoxifen—CYP2B6—malignant glioma	0.517	1	CbGaD
Tamoxifen—CYP1A2—Carmustine—malignant glioma	0.0503	0.57	CbGbCtD
Tamoxifen—CYP3A4—Temozolomide—malignant glioma	0.0381	0.431	CbGbCtD
Tamoxifen—Ocular toxicity—Carmustine—malignant glioma	0.0103	0.0677	CcSEcCtD
Tamoxifen—Metastatic neoplasm—Temozolomide—malignant glioma	0.00702	0.0462	CcSEcCtD
Tamoxifen—Disease progression—Carmustine—malignant glioma	0.00638	0.042	CcSEcCtD
Tamoxifen—Myelosuppression—Carmustine—malignant glioma	0.00297	0.0195	CcSEcCtD
Tamoxifen—Myelosuppression—Temozolomide—malignant glioma	0.00287	0.0189	CcSEcCtD
Tamoxifen—Interstitial pneumonia—Temozolomide—malignant glioma	0.00279	0.0183	CcSEcCtD
Tamoxifen—SULT1A1—telencephalon—malignant glioma	0.00232	0.0409	CbGeAlD
Tamoxifen—Febrile neutropenia—Carmustine—malignant glioma	0.00232	0.0152	CcSEcCtD
Tamoxifen—Visual acuity reduced—Temozolomide—malignant glioma	0.00226	0.0149	CcSEcCtD
Tamoxifen—Febrile neutropenia—Temozolomide—malignant glioma	0.00224	0.0147	CcSEcCtD
Tamoxifen—Deep vein thrombosis—Temozolomide—malignant glioma	0.00221	0.0146	CcSEcCtD
Tamoxifen—Embolism—Temozolomide—malignant glioma	0.0021	0.0138	CcSEcCtD
Tamoxifen—Cyst—Carmustine—malignant glioma	0.00208	0.0137	CcSEcCtD
Tamoxifen—Interstitial lung disease—Carmustine—malignant glioma	0.00197	0.0129	CcSEcCtD
Tamoxifen—Thrombosis—Carmustine—malignant glioma	0.00197	0.0129	CcSEcCtD
Tamoxifen—Interstitial lung disease—Temozolomide—malignant glioma	0.0019	0.0125	CcSEcCtD
Tamoxifen—Vaginal haemorrhage—Temozolomide—malignant glioma	0.00182	0.012	CcSEcCtD
Tamoxifen—Hepatotoxicity—Carmustine—malignant glioma	0.0018	0.0119	CcSEcCtD
Tamoxifen—DHCR7—retina—malignant glioma	0.00179	0.0316	CbGeAlD
Tamoxifen—Cholestasis—Temozolomide—malignant glioma	0.00177	0.0117	CcSEcCtD
Tamoxifen—Hepatotoxicity—Temozolomide—malignant glioma	0.00174	0.0115	CcSEcCtD
Tamoxifen—EBPL—central nervous system—malignant glioma	0.00166	0.0292	CbGeAlD
Tamoxifen—DHCR7—telencephalon—malignant glioma	0.00165	0.0291	CbGeAlD
Tamoxifen—SULT1A1—spinal cord—malignant glioma	0.00162	0.0286	CbGeAlD
Tamoxifen—EBPL—cerebellum—malignant glioma	0.00162	0.0286	CbGeAlD
Tamoxifen—Liver injury—Temozolomide—malignant glioma	0.0016	0.0105	CcSEcCtD
Tamoxifen—Accidental injury—Carmustine—malignant glioma	0.00157	0.0104	CcSEcCtD
Tamoxifen—Breast pain—Temozolomide—malignant glioma	0.00154	0.0101	CcSEcCtD
Tamoxifen—Amenorrhoea—Temozolomide—malignant glioma	0.00153	0.0101	CcSEcCtD
Tamoxifen—Drug interaction—Carmustine—malignant glioma	0.0015	0.00988	CcSEcCtD
Tamoxifen—Gait disturbance—Carmustine—malignant glioma	0.00143	0.00939	CcSEcCtD
Tamoxifen—Pulmonary embolism—Carmustine—malignant glioma	0.00139	0.00916	CcSEcCtD
Tamoxifen—Gait disturbance—Temozolomide—malignant glioma	0.00138	0.00907	CcSEcCtD
Tamoxifen—ESR1—blood vessel—malignant glioma	0.00137	0.0242	CbGeAlD
Tamoxifen—Musculoskeletal pain—Temozolomide—malignant glioma	0.00136	0.00896	CcSEcCtD
Tamoxifen—Vaginal inflammation—Temozolomide—malignant glioma	0.00135	0.00885	CcSEcCtD
Tamoxifen—Pulmonary embolism—Temozolomide—malignant glioma	0.00135	0.00885	CcSEcCtD
Tamoxifen—Urinary incontinence—Carmustine—malignant glioma	0.00135	0.00885	CcSEcCtD
Tamoxifen—Skin exfoliation—Carmustine—malignant glioma	0.00133	0.00875	CcSEcCtD
Tamoxifen—SULT1A1—central nervous system—malignant glioma	0.00132	0.0232	CbGeAlD
Tamoxifen—EBPL—brain—malignant glioma	0.00132	0.0232	CbGeAlD
Tamoxifen—Urinary incontinence—Temozolomide—malignant glioma	0.0013	0.00855	CcSEcCtD
Tamoxifen—DHCR7—medulla oblongata—malignant glioma	0.00129	0.0228	CbGeAlD
Tamoxifen—SULT1A1—cerebellum—malignant glioma	0.00129	0.0227	CbGeAlD
Tamoxifen—Skin exfoliation—Temozolomide—malignant glioma	0.00129	0.00845	CcSEcCtD
Tamoxifen—ESRRA—medulla oblongata—malignant glioma	0.00127	0.0225	CbGeAlD
Tamoxifen—Vaginal infection—Temozolomide—malignant glioma	0.00127	0.00836	CcSEcCtD
Tamoxifen—Neoplasm—Carmustine—malignant glioma	0.00126	0.00828	CcSEcCtD
Tamoxifen—Neoplasm—Temozolomide—malignant glioma	0.00122	0.008	CcSEcCtD
Tamoxifen—Sepsis—Carmustine—malignant glioma	0.00121	0.00795	CcSEcCtD
Tamoxifen—DHCR7—midbrain—malignant glioma	0.00118	0.0209	CbGeAlD
Tamoxifen—ESRRA—midbrain—malignant glioma	0.00116	0.0205	CbGeAlD
Tamoxifen—DHCR7—spinal cord—malignant glioma	0.00115	0.0204	CbGeAlD
Tamoxifen—Swelling—Carmustine—malignant glioma	0.00115	0.00754	CcSEcCtD
Tamoxifen—ESRRA—spinal cord—malignant glioma	0.00114	0.02	CbGeAlD
Tamoxifen—Benzphetamine—POR—malignant glioma	0.00111	0.213	CrCbGaD
Tamoxifen—Injury—Carmustine—malignant glioma	0.0011	0.00723	CcSEcCtD
Tamoxifen—ESR2—brainstem—malignant glioma	0.0011	0.0193	CbGeAlD
Tamoxifen—Hepatic failure—Temozolomide—malignant glioma	0.00109	0.00715	CcSEcCtD
Tamoxifen—SULT1A1—brain—malignant glioma	0.00105	0.0184	CbGeAlD
Tamoxifen—Hot flush—Temozolomide—malignant glioma	0.00104	0.00687	CcSEcCtD
Tamoxifen—Menopausal symptoms—Temozolomide—malignant glioma	0.00104	0.00681	CcSEcCtD
Tamoxifen—Thirst—Temozolomide—malignant glioma	0.00103	0.00675	CcSEcCtD
Tamoxifen—ESR2—telencephalon—malignant glioma	0.000973	0.0172	CbGeAlD
Tamoxifen—Ospemifene—CYP2B6—malignant glioma	0.00095	0.183	CrCbGaD
Tamoxifen—DHCR7—central nervous system—malignant glioma	0.000936	0.0165	CbGeAlD
Tamoxifen—FMO1—central nervous system—malignant glioma	0.000936	0.0165	CbGeAlD
Tamoxifen—Liver function test abnormal—Carmustine—malignant glioma	0.000934	0.00614	CcSEcCtD
Tamoxifen—Mood swings—Temozolomide—malignant glioma	0.000926	0.00609	CcSEcCtD
Tamoxifen—ESRRA—central nervous system—malignant glioma	0.000922	0.0163	CbGeAlD
Tamoxifen—DHCR7—cerebellum—malignant glioma	0.000915	0.0161	CbGeAlD
Tamoxifen—ESRRA—cerebellum—malignant glioma	0.000901	0.0159	CbGeAlD
Tamoxifen—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00088	0.00579	CcSEcCtD
Tamoxifen—Dysphagia—Carmustine—malignant glioma	0.000874	0.00575	CcSEcCtD
Tamoxifen—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.000862	0.00567	CcSEcCtD
Tamoxifen—Dysphagia—Temozolomide—malignant glioma	0.000845	0.00555	CcSEcCtD
Tamoxifen—Pancytopenia—Carmustine—malignant glioma	0.00083	0.00546	CcSEcCtD
Tamoxifen—ESR1—embryo—malignant glioma	0.00082	0.0145	CbGeAlD
Tamoxifen—Neutropenia—Carmustine—malignant glioma	0.000817	0.00537	CcSEcCtD
Tamoxifen—Bronchitis—Temozolomide—malignant glioma	0.000812	0.00534	CcSEcCtD
Tamoxifen—FMO3—central nervous system—malignant glioma	0.000809	0.0143	CbGeAlD
Tamoxifen—Pancytopenia—Temozolomide—malignant glioma	0.000802	0.00527	CcSEcCtD
Tamoxifen—Neutropenia—Temozolomide—malignant glioma	0.00079	0.00519	CcSEcCtD
Tamoxifen—Pneumonia—Carmustine—malignant glioma	0.000784	0.00515	CcSEcCtD
Tamoxifen—Erectile dysfunction—Temozolomide—malignant glioma	0.000778	0.00512	CcSEcCtD
Tamoxifen—Depression—Carmustine—malignant glioma	0.000777	0.00511	CcSEcCtD
Tamoxifen—Weight increased—Temozolomide—malignant glioma	0.000769	0.00505	CcSEcCtD
Tamoxifen—Weight decreased—Temozolomide—malignant glioma	0.000764	0.00502	CcSEcCtD
Tamoxifen—Urinary tract infection—Carmustine—malignant glioma	0.000758	0.00498	CcSEcCtD
Tamoxifen—Pneumonia—Temozolomide—malignant glioma	0.000757	0.00498	CcSEcCtD
Tamoxifen—SIGMAR1—telencephalon—malignant glioma	0.000754	0.0133	CbGeAlD
Tamoxifen—ESR1—brainstem—malignant glioma	0.000751	0.0133	CbGeAlD
Tamoxifen—Depression—Temozolomide—malignant glioma	0.000751	0.00494	CcSEcCtD
Tamoxifen—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.000747	0.00491	CcSEcCtD
Tamoxifen—DHCR7—brain—malignant glioma	0.000743	0.0131	CbGeAlD
Tamoxifen—FMO1—brain—malignant glioma	0.000743	0.0131	CbGeAlD
Tamoxifen—Urinary tract infection—Temozolomide—malignant glioma	0.000732	0.00481	CcSEcCtD
Tamoxifen—ESRRA—brain—malignant glioma	0.000732	0.0129	CbGeAlD
Tamoxifen—CYP1B1—telencephalon—malignant glioma	0.000717	0.0127	CbGeAlD
Tamoxifen—Sinusitis—Temozolomide—malignant glioma	0.000707	0.00465	CcSEcCtD
Tamoxifen—Haemoglobin—Carmustine—malignant glioma	0.000703	0.00462	CcSEcCtD
Tamoxifen—Haemorrhage—Carmustine—malignant glioma	0.0007	0.0046	CcSEcCtD
Tamoxifen—Hypoaesthesia—Carmustine—malignant glioma	0.000696	0.00458	CcSEcCtD
Tamoxifen—Oedema peripheral—Carmustine—malignant glioma	0.000689	0.00453	CcSEcCtD
Tamoxifen—Haemoglobin—Temozolomide—malignant glioma	0.00068	0.00447	CcSEcCtD
Tamoxifen—Hepatitis—Temozolomide—malignant glioma	0.000676	0.00445	CcSEcCtD
Tamoxifen—Haemorrhage—Temozolomide—malignant glioma	0.000676	0.00445	CcSEcCtD
Tamoxifen—Visual impairment—Carmustine—malignant glioma	0.000674	0.00443	CcSEcCtD
Tamoxifen—Hypoaesthesia—Temozolomide—malignant glioma	0.000673	0.00442	CcSEcCtD
Tamoxifen—Pharyngitis—Temozolomide—malignant glioma	0.000671	0.00441	CcSEcCtD
Tamoxifen—ESR1—telencephalon—malignant glioma	0.000667	0.0118	CbGeAlD
Tamoxifen—Oedema peripheral—Temozolomide—malignant glioma	0.000666	0.00438	CcSEcCtD
Tamoxifen—Visual impairment—Temozolomide—malignant glioma	0.000652	0.00428	CcSEcCtD
Tamoxifen—Flushing—Carmustine—malignant glioma	0.000649	0.00427	CcSEcCtD
Tamoxifen—FMO3—brain—malignant glioma	0.000643	0.0113	CbGeAlD
Tamoxifen—Erythema multiforme—Temozolomide—malignant glioma	0.000639	0.0042	CcSEcCtD
Tamoxifen—CES1—central nervous system—malignant glioma	0.000639	0.0113	CbGeAlD
Tamoxifen—Flushing—Temozolomide—malignant glioma	0.000627	0.00413	CcSEcCtD
Tamoxifen—Arrhythmia—Carmustine—malignant glioma	0.000625	0.00411	CcSEcCtD
Tamoxifen—Alopecia—Carmustine—malignant glioma	0.000618	0.00407	CcSEcCtD
Tamoxifen—Erythema—Carmustine—malignant glioma	0.000609	0.004	CcSEcCtD
Tamoxifen—Alopecia—Temozolomide—malignant glioma	0.000597	0.00393	CcSEcCtD
Tamoxifen—SIGMAR1—medulla oblongata—malignant glioma	0.000593	0.0105	CbGeAlD
Tamoxifen—Back pain—Carmustine—malignant glioma	0.000589	0.00387	CcSEcCtD
Tamoxifen—Erythema—Temozolomide—malignant glioma	0.000589	0.00387	CcSEcCtD
Tamoxifen—Dysgeusia—Temozolomide—malignant glioma	0.000576	0.00379	CcSEcCtD
Tamoxifen—Back pain—Temozolomide—malignant glioma	0.000569	0.00374	CcSEcCtD
Tamoxifen—Anaemia—Carmustine—malignant glioma	0.000563	0.0037	CcSEcCtD
Tamoxifen—ESR2—central nervous system—malignant glioma	0.000553	0.00976	CbGeAlD
Tamoxifen—Leukopenia—Carmustine—malignant glioma	0.000545	0.00358	CcSEcCtD
Tamoxifen—Anaemia—Temozolomide—malignant glioma	0.000544	0.00358	CcSEcCtD
Tamoxifen—CYP2A6—cerebellum—malignant glioma	0.000544	0.00959	CbGeAlD
Tamoxifen—ABCB1—blood vessel—malignant glioma	0.000543	0.00957	CbGeAlD
Tamoxifen—SIGMAR1—midbrain—malignant glioma	0.000542	0.00955	CbGeAlD
Tamoxifen—ESR2—cerebellum—malignant glioma	0.000541	0.00954	CbGeAlD
Tamoxifen—Angioedema—Temozolomide—malignant glioma	0.000538	0.00354	CcSEcCtD
Tamoxifen—ABCG2—telencephalon—malignant glioma	0.000534	0.00942	CbGeAlD
Tamoxifen—SIGMAR1—spinal cord—malignant glioma	0.000528	0.00932	CbGeAlD
Tamoxifen—Leukopenia—Temozolomide—malignant glioma	0.000527	0.00346	CcSEcCtD
Tamoxifen—Hypertension—Carmustine—malignant glioma	0.000526	0.00346	CcSEcCtD
Tamoxifen—Myalgia—Carmustine—malignant glioma	0.000518	0.00341	CcSEcCtD
Tamoxifen—Chest pain—Carmustine—malignant glioma	0.000518	0.00341	CcSEcCtD
Tamoxifen—Anxiety—Carmustine—malignant glioma	0.000517	0.0034	CcSEcCtD
Tamoxifen—Cough—Temozolomide—malignant glioma	0.000514	0.00338	CcSEcCtD
Tamoxifen—Hypertension—Temozolomide—malignant glioma	0.000508	0.00334	CcSEcCtD
Tamoxifen—CES1—brain—malignant glioma	0.000507	0.00895	CbGeAlD
Tamoxifen—Myalgia—Temozolomide—malignant glioma	0.000501	0.00329	CcSEcCtD
Tamoxifen—Arthralgia—Temozolomide—malignant glioma	0.000501	0.00329	CcSEcCtD
Tamoxifen—Anxiety—Temozolomide—malignant glioma	0.000499	0.00328	CcSEcCtD
Tamoxifen—Oedema—Carmustine—malignant glioma	0.000497	0.00327	CcSEcCtD
Tamoxifen—Discomfort—Temozolomide—malignant glioma	0.000495	0.00326	CcSEcCtD
Tamoxifen—Infection—Carmustine—malignant glioma	0.000494	0.00325	CcSEcCtD
Tamoxifen—Dry mouth—Temozolomide—malignant glioma	0.00049	0.00322	CcSEcCtD
Tamoxifen—Thrombocytopenia—Carmustine—malignant glioma	0.000487	0.0032	CcSEcCtD
Tamoxifen—Oedema—Temozolomide—malignant glioma	0.00048	0.00316	CcSEcCtD
Tamoxifen—Infection—Temozolomide—malignant glioma	0.000477	0.00314	CcSEcCtD
Tamoxifen—Anorexia—Carmustine—malignant glioma	0.000474	0.00312	CcSEcCtD
Tamoxifen—Thrombocytopenia—Temozolomide—malignant glioma	0.00047	0.00309	CcSEcCtD
Tamoxifen—Hyperhidrosis—Temozolomide—malignant glioma	0.000464	0.00305	CcSEcCtD
Tamoxifen—CYP2E1—telencephalon—malignant glioma	0.000462	0.00816	CbGeAlD
Tamoxifen—Anorexia—Temozolomide—malignant glioma	0.000458	0.00301	CcSEcCtD
Tamoxifen—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000453	0.00298	CcSEcCtD
Tamoxifen—Insomnia—Carmustine—malignant glioma	0.00045	0.00296	CcSEcCtD
Tamoxifen—Paraesthesia—Carmustine—malignant glioma	0.000446	0.00293	CcSEcCtD
Tamoxifen—Dyspnoea—Carmustine—malignant glioma	0.000443	0.00291	CcSEcCtD
Tamoxifen—CYP2A6—brain—malignant glioma	0.000441	0.00779	CbGeAlD
Tamoxifen—ESR2—brain—malignant glioma	0.000439	0.00775	CbGeAlD
Tamoxifen—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000438	0.00288	CcSEcCtD
Tamoxifen—CYP19A1—central nervous system—malignant glioma	0.000436	0.00769	CbGeAlD
Tamoxifen—Insomnia—Temozolomide—malignant glioma	0.000434	0.00286	CcSEcCtD
Tamoxifen—Decreased appetite—Carmustine—malignant glioma	0.000432	0.00284	CcSEcCtD
Tamoxifen—Paraesthesia—Temozolomide—malignant glioma	0.000431	0.00284	CcSEcCtD
Tamoxifen—Loperamide—CYP2B6—malignant glioma	0.000431	0.0828	CrCbGaD
Tamoxifen—Gastrointestinal disorder—Carmustine—malignant glioma	0.000429	0.00282	CcSEcCtD
Tamoxifen—Dyspnoea—Temozolomide—malignant glioma	0.000428	0.00282	CcSEcCtD
Tamoxifen—Diphenhydramine—CYP2C18—malignant glioma	0.000428	0.0823	CrCbGaD
Tamoxifen—Constipation—Carmustine—malignant glioma	0.000425	0.00279	CcSEcCtD
Tamoxifen—Pain—Carmustine—malignant glioma	0.000425	0.00279	CcSEcCtD
Tamoxifen—Dyspepsia—Temozolomide—malignant glioma	0.000423	0.00278	CcSEcCtD
Tamoxifen—ABCG2—medulla oblongata—malignant glioma	0.00042	0.0074	CbGeAlD
Tamoxifen—SIGMAR1—cerebellum—malignant glioma	0.000419	0.00739	CbGeAlD
Tamoxifen—Decreased appetite—Temozolomide—malignant glioma	0.000418	0.00275	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000415	0.00273	CcSEcCtD
Tamoxifen—Fatigue—Temozolomide—malignant glioma	0.000414	0.00272	CcSEcCtD
Tamoxifen—Methadone—CYP2C18—malignant glioma	0.000413	0.0795	CrCbGaD
Tamoxifen—CYP2D6—brainstem—malignant glioma	0.000412	0.00728	CbGeAlD
Tamoxifen—Pain—Temozolomide—malignant glioma	0.000411	0.0027	CcSEcCtD
Tamoxifen—Constipation—Temozolomide—malignant glioma	0.000411	0.0027	CcSEcCtD
Tamoxifen—CYP1B1—central nervous system—malignant glioma	0.000408	0.00719	CbGeAlD
Tamoxifen—Gastrointestinal pain—Carmustine—malignant glioma	0.000406	0.00267	CcSEcCtD
Tamoxifen—CYP1B1—cerebellum—malignant glioma	0.000398	0.00703	CbGeAlD
Tamoxifen—Benzphetamine—CYP2B6—malignant glioma	0.000396	0.0762	CrCbGaD
Tamoxifen—Abdominal pain—Carmustine—malignant glioma	0.000393	0.00258	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Temozolomide—malignant glioma	0.000393	0.00258	CcSEcCtD
Tamoxifen—ABCG2—midbrain—malignant glioma	0.000383	0.00676	CbGeAlD
Tamoxifen—Urticaria—Temozolomide—malignant glioma	0.000382	0.00251	CcSEcCtD
Tamoxifen—Abdominal pain—Temozolomide—malignant glioma	0.00038	0.0025	CcSEcCtD
Tamoxifen—ESR1—central nervous system—malignant glioma	0.000379	0.00668	CbGeAlD
Tamoxifen—ABCG2—spinal cord—malignant glioma	0.000374	0.0066	CbGeAlD
Tamoxifen—ESR1—cerebellum—malignant glioma	0.00037	0.00653	CbGeAlD
Tamoxifen—Hypersensitivity—Carmustine—malignant glioma	0.000366	0.00241	CcSEcCtD
Tamoxifen—CYP2D6—telencephalon—malignant glioma	0.000366	0.00646	CbGeAlD
Tamoxifen—CYP2E1—medulla oblongata—malignant glioma	0.000363	0.00641	CbGeAlD
Tamoxifen—Asthenia—Carmustine—malignant glioma	0.000357	0.00234	CcSEcCtD
Tamoxifen—Hypersensitivity—Temozolomide—malignant glioma	0.000354	0.00233	CcSEcCtD
Tamoxifen—CYP19A1—brain—malignant glioma	0.000346	0.00611	CbGeAlD
Tamoxifen—Asthenia—Temozolomide—malignant glioma	0.000345	0.00227	CcSEcCtD
Tamoxifen—SIGMAR1—brain—malignant glioma	0.00034	0.006	CbGeAlD
Tamoxifen—Diarrhoea—Carmustine—malignant glioma	0.00034	0.00224	CcSEcCtD
Tamoxifen—Pruritus—Temozolomide—malignant glioma	0.00034	0.00223	CcSEcCtD
Tamoxifen—Benzphetamine—SLC6A3—malignant glioma	0.000338	0.065	CrCbGaD
Tamoxifen—Dizziness—Carmustine—malignant glioma	0.000329	0.00216	CcSEcCtD
Tamoxifen—Diarrhoea—Temozolomide—malignant glioma	0.000329	0.00216	CcSEcCtD
Tamoxifen—CYP2E1—spinal cord—malignant glioma	0.000324	0.00571	CbGeAlD
Tamoxifen—ABCB1—embryo—malignant glioma	0.000324	0.00571	CbGeAlD
Tamoxifen—CYP1B1—brain—malignant glioma	0.000324	0.00571	CbGeAlD
Tamoxifen—Dizziness—Temozolomide—malignant glioma	0.000318	0.00209	CcSEcCtD
Tamoxifen—Diphenhydramine—CYP2B6—malignant glioma	0.000318	0.0611	CrCbGaD
Tamoxifen—Vomiting—Carmustine—malignant glioma	0.000316	0.00208	CcSEcCtD
Tamoxifen—Rash—Carmustine—malignant glioma	0.000313	0.00206	CcSEcCtD
Tamoxifen—Dermatitis—Carmustine—malignant glioma	0.000313	0.00206	CcSEcCtD
Tamoxifen—Headache—Carmustine—malignant glioma	0.000311	0.00205	CcSEcCtD
Tamoxifen—Methadone—CYP2B6—malignant glioma	0.000307	0.059	CrCbGaD
Tamoxifen—Vomiting—Temozolomide—malignant glioma	0.000305	0.00201	CcSEcCtD
Tamoxifen—Rash—Temozolomide—malignant glioma	0.000303	0.00199	CcSEcCtD
Tamoxifen—Dermatitis—Temozolomide—malignant glioma	0.000303	0.00199	CcSEcCtD
Tamoxifen—Headache—Temozolomide—malignant glioma	0.000301	0.00198	CcSEcCtD
Tamoxifen—ESR1—brain—malignant glioma	0.000301	0.00531	CbGeAlD
Tamoxifen—Orphenadrine—CYP2B6—malignant glioma	0.0003	0.0578	CrCbGaD
Tamoxifen—ABCG2—cerebellum—malignant glioma	0.000297	0.00523	CbGeAlD
Tamoxifen—Nausea—Carmustine—malignant glioma	0.000295	0.00194	CcSEcCtD
Tamoxifen—CYP1A1—central nervous system—malignant glioma	0.000288	0.00508	CbGeAlD
Tamoxifen—ABCB1—retina—malignant glioma	0.000286	0.00505	CbGeAlD
Tamoxifen—Nausea—Temozolomide—malignant glioma	0.000285	0.00188	CcSEcCtD
Tamoxifen—CYP2B6—central nervous system—malignant glioma	0.00028	0.00494	CbGeAlD
Tamoxifen—ABCB1—telencephalon—malignant glioma	0.000263	0.00465	CbGeAlD
Tamoxifen—CYP2E1—central nervous system—malignant glioma	0.000263	0.00464	CbGeAlD
Tamoxifen—CYP2E1—cerebellum—malignant glioma	0.000257	0.00453	CbGeAlD
Tamoxifen—CYP2C8—brain—malignant glioma	0.000248	0.00437	CbGeAlD
Tamoxifen—ABCG2—brain—malignant glioma	0.000241	0.00425	CbGeAlD
Tamoxifen—CYP1A1—brain—malignant glioma	0.000229	0.00404	CbGeAlD
Tamoxifen—CYP2B6—brain—malignant glioma	0.000222	0.00392	CbGeAlD
Tamoxifen—CYP3A4—central nervous system—malignant glioma	0.000211	0.00373	CbGeAlD
Tamoxifen—Diphenhydramine—PTGS1—malignant glioma	0.000209	0.0402	CrCbGaD
Tamoxifen—CYP2E1—brain—malignant glioma	0.000209	0.00368	CbGeAlD
Tamoxifen—CYP2D6—central nervous system—malignant glioma	0.000208	0.00367	CbGeAlD
Tamoxifen—ABCB1—medulla oblongata—malignant glioma	0.000207	0.00365	CbGeAlD
Tamoxifen—CYP2D6—cerebellum—malignant glioma	0.000203	0.00359	CbGeAlD
Tamoxifen—ABCB1—midbrain—malignant glioma	0.000189	0.00334	CbGeAlD
Tamoxifen—ABCB1—spinal cord—malignant glioma	0.000184	0.00325	CbGeAlD
Tamoxifen—CYP2D6—brain—malignant glioma	0.000165	0.00291	CbGeAlD
Tamoxifen—ABCB1—central nervous system—malignant glioma	0.00015	0.00264	CbGeAlD
Tamoxifen—ABCB1—cerebellum—malignant glioma	0.000146	0.00258	CbGeAlD
Tamoxifen—ABCB1—brain—malignant glioma	0.000119	0.0021	CbGeAlD
Tamoxifen—ESR1—Signaling Pathways—TERT—malignant glioma	7.61e-06	4.21e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PTGS1—malignant glioma	7.57e-06	4.19e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—SLC5A5—malignant glioma	7.56e-06	4.19e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	7.55e-06	4.18e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CYP2B6—malignant glioma	7.54e-06	4.17e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—PIK3CD—malignant glioma	7.53e-06	4.17e-05	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—PTEN—malignant glioma	7.52e-06	4.16e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PTGS1—malignant glioma	7.51e-06	4.16e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PIK3CG—malignant glioma	7.5e-06	4.15e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—CAV1—malignant glioma	7.48e-06	4.14e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	7.48e-06	4.14e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—BCHE—malignant glioma	7.47e-06	4.14e-05	CbGpPWpGaD
Tamoxifen—ESR2—Gene Expression—AKT1—malignant glioma	7.46e-06	4.13e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—GSTP1—malignant glioma	7.44e-06	4.12e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PIK3CG—malignant glioma	7.44e-06	4.12e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PDGFB—malignant glioma	7.43e-06	4.11e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—NCOR1—malignant glioma	7.41e-06	4.1e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—FGFR1—malignant glioma	7.39e-06	4.09e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—SLC5A5—malignant glioma	7.38e-06	4.09e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—HIF1A—malignant glioma	7.28e-06	4.03e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	7.27e-06	4.03e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—NCOR1—malignant glioma	7.26e-06	4.02e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—PIK3CD—malignant glioma	7.25e-06	4.01e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—CAT—malignant glioma	7.24e-06	4.01e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PPARG—malignant glioma	7.24e-06	4.01e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—NCOR1—malignant glioma	7.24e-06	4.01e-05	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—PIK3CA—malignant glioma	7.19e-06	3.98e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PPARG—malignant glioma	7.18e-06	3.97e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	7.15e-06	3.96e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	7.09e-06	3.92e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—BCHE—malignant glioma	7.04e-06	3.9e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CAV1—malignant glioma	7.04e-06	3.9e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	7.02e-06	3.89e-05	CbGpPWpGaD
Tamoxifen—FMO3—Metabolism—AKT1—malignant glioma	7.01e-06	3.88e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—BCHE—malignant glioma	6.98e-06	3.87e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—KDR—malignant glioma	6.96e-06	3.85e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—SLC5A5—malignant glioma	6.96e-06	3.85e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	6.92e-06	3.83e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—SLC5A5—malignant glioma	6.9e-06	3.82e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—IDH1—malignant glioma	6.89e-06	3.82e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GSTT1—malignant glioma	6.85e-06	3.79e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—NCOR1—malignant glioma	6.84e-06	3.79e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—GSTP1—malignant glioma	6.82e-06	3.78e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PIK3CG—malignant glioma	6.82e-06	3.77e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	6.8e-06	3.76e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—FN1—malignant glioma	6.7e-06	3.71e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—F2—malignant glioma	6.7e-06	3.71e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—SPHK1—malignant glioma	6.67e-06	3.69e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—CAT—malignant glioma	6.64e-06	3.68e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—BAD—malignant glioma	6.62e-06	3.67e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PIK3CD—malignant glioma	6.6e-06	3.65e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PPARG—malignant glioma	6.58e-06	3.64e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—PIK3CB—malignant glioma	6.56e-06	3.63e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—NOTCH1—malignant glioma	6.56e-06	3.63e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PIK3CD—malignant glioma	6.54e-06	3.62e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CYP2C18—malignant glioma	6.53e-06	3.62e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	6.52e-06	3.61e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—PTGS2—malignant glioma	6.5e-06	3.6e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	6.46e-06	3.58e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CD80—malignant glioma	6.42e-06	3.56e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PTGS1—malignant glioma	6.42e-06	3.55e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PIK3CG—malignant glioma	6.41e-06	3.55e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—APC—malignant glioma	6.41e-06	3.55e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	6.39e-06	3.54e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—EGF—malignant glioma	6.34e-06	3.51e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—PIK3CB—malignant glioma	6.32e-06	3.5e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PTPN11—malignant glioma	6.3e-06	3.49e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—NCOR1—malignant glioma	6.27e-06	3.47e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—PTGS2—malignant glioma	6.26e-06	3.47e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	6.18e-06	3.42e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—GSTP1—malignant glioma	6.09e-06	3.37e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—CAV1—malignant glioma	6.04e-06	3.34e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—BRAF—malignant glioma	6.03e-06	3.34e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PIK3CD—malignant glioma	5.99e-06	3.32e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—BCHE—malignant glioma	5.97e-06	3.3e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—GSTP1—malignant glioma	5.95e-06	3.29e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—CAT—malignant glioma	5.93e-06	3.28e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—CAV1—malignant glioma	5.91e-06	3.27e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—CAV1—malignant glioma	5.9e-06	3.27e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—SLC5A5—malignant glioma	5.89e-06	3.26e-05	CbGpPWpGaD
Tamoxifen—UGT1A4—Metabolism—AKT1—malignant glioma	5.88e-06	3.25e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—AKT2—malignant glioma	5.87e-06	3.25e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—CAT—malignant glioma	5.79e-06	3.2e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PIK3CB—malignant glioma	5.75e-06	3.18e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PIK3CB—malignant glioma	5.7e-06	3.16e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PTGS2—malignant glioma	5.7e-06	3.15e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—PTEN—malignant glioma	5.67e-06	3.14e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PTGS2—malignant glioma	5.65e-06	3.13e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PIK3CD—malignant glioma	5.64e-06	3.12e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	5.63e-06	3.12e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—GSTP1—malignant glioma	5.6e-06	3.1e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—NCOR1—malignant glioma	5.6e-06	3.1e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—CAV1—malignant glioma	5.58e-06	3.09e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	5.57e-06	3.09e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—GSTP1—malignant glioma	5.55e-06	3.08e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	5.52e-06	3.06e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PIK3CG—malignant glioma	5.5e-06	3.05e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—NCOR1—malignant glioma	5.46e-06	3.03e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—PTEN—malignant glioma	5.46e-06	3.02e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—CAT—malignant glioma	5.45e-06	3.02e-05	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—MYC—malignant glioma	5.43e-06	3e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—CAT—malignant glioma	5.4e-06	2.99e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—FGF2—malignant glioma	5.4e-06	2.99e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PIK3CG—malignant glioma	5.39e-06	2.98e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PIK3CG—malignant glioma	5.38e-06	2.98e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.33e-06	2.95e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PPARG—malignant glioma	5.31e-06	2.94e-05	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—PIK3CA—malignant glioma	5.3e-06	2.94e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GSTT1—malignant glioma	5.28e-06	2.93e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PIK3CB—malignant glioma	5.22e-06	2.89e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PPARG—malignant glioma	5.2e-06	2.88e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PPARG—malignant glioma	5.19e-06	2.87e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PTGS2—malignant glioma	5.18e-06	2.87e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—NCOR1—malignant glioma	5.15e-06	2.85e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—CAV1—malignant glioma	5.11e-06	2.83e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—NCOR1—malignant glioma	5.1e-06	2.83e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PIK3CG—malignant glioma	5.08e-06	2.81e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MDM2—malignant glioma	5.05e-06	2.8e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—RAF1—malignant glioma	5.03e-06	2.79e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—ERBB2—malignant glioma	4.98e-06	2.76e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PTEN—malignant glioma	4.97e-06	2.75e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PTGS1—malignant glioma	4.95e-06	2.74e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PTEN—malignant glioma	4.92e-06	2.73e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PIK3CB—malignant glioma	4.91e-06	2.72e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PPARG—malignant glioma	4.9e-06	2.71e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.88e-06	2.7e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PIK3CD—malignant glioma	4.84e-06	2.68e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	4.81e-06	2.67e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—GSTP1—malignant glioma	4.75e-06	2.63e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PIK3CD—malignant glioma	4.74e-06	2.62e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PIK3CD—malignant glioma	4.73e-06	2.62e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CXCL8—malignant glioma	4.72e-06	2.61e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PIK3CG—malignant glioma	4.66e-06	2.58e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CAT—malignant glioma	4.62e-06	2.56e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—BCHE—malignant glioma	4.6e-06	2.55e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—CAV1—malignant glioma	4.56e-06	2.53e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—SLC5A5—malignant glioma	4.55e-06	2.52e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—CASP3—malignant glioma	4.52e-06	2.5e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PTEN—malignant glioma	4.51e-06	2.5e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—IL2—malignant glioma	4.51e-06	2.5e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PPARG—malignant glioma	4.49e-06	2.49e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PIK3CD—malignant glioma	4.47e-06	2.47e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—CAV1—malignant glioma	4.45e-06	2.47e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—NCOR1—malignant glioma	4.36e-06	2.42e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.36e-06	2.41e-05	CbGpPWpGaD
Tamoxifen—ABCB11—Metabolism—AKT1—malignant glioma	4.33e-06	2.4e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MMP9—malignant glioma	4.27e-06	2.36e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PTEN—malignant glioma	4.25e-06	2.35e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PIK3CB—malignant glioma	4.21e-06	2.33e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—CAV1—malignant glioma	4.2e-06	2.32e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PTGS2—malignant glioma	4.18e-06	2.31e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—CAV1—malignant glioma	4.16e-06	2.3e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PIK3CG—malignant glioma	4.16e-06	2.3e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PIK3CB—malignant glioma	4.13e-06	2.29e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PIK3CB—malignant glioma	4.12e-06	2.28e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PIK3CD—malignant glioma	4.09e-06	2.27e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PTGS2—malignant glioma	4.09e-06	2.26e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PTGS2—malignant glioma	4.08e-06	2.26e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PIK3CG—malignant glioma	4.06e-06	2.25e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PPARG—malignant glioma	4.01e-06	2.22e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—PIK3CA—malignant glioma	4e-06	2.22e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.98e-06	2.2e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PPARG—malignant glioma	3.92e-06	2.17e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PIK3CB—malignant glioma	3.89e-06	2.16e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PTGS2—malignant glioma	3.86e-06	2.14e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—PIK3CA—malignant glioma	3.85e-06	2.13e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—VEGFA—malignant glioma	3.83e-06	2.12e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PIK3CG—malignant glioma	3.82e-06	2.12e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—STAT3—malignant glioma	3.8e-06	2.1e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PIK3CG—malignant glioma	3.79e-06	2.1e-05	CbGpPWpGaD
Tamoxifen—ESR1—Gene Expression—AKT1—malignant glioma	3.76e-06	2.08e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PPARG—malignant glioma	3.69e-06	2.04e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—GSTP1—malignant glioma	3.66e-06	2.03e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PPARG—malignant glioma	3.66e-06	2.03e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PIK3CD—malignant glioma	3.65e-06	2.02e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PTEN—malignant glioma	3.64e-06	2.02e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PIK3CB—malignant glioma	3.57e-06	1.98e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PTEN—malignant glioma	3.57e-06	1.98e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PIK3CD—malignant glioma	3.57e-06	1.97e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CAT—malignant glioma	3.56e-06	1.97e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PTEN—malignant glioma	3.56e-06	1.97e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—CAV1—malignant glioma	3.56e-06	1.97e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PTGS2—malignant glioma	3.54e-06	1.96e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—MYC—malignant glioma	3.53e-06	1.95e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—PIK3CA—malignant glioma	3.5e-06	1.94e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—PIK3CA—malignant glioma	3.47e-06	1.92e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—EGFR—malignant glioma	3.45e-06	1.91e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	3.4e-06	1.88e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—NCOR1—malignant glioma	3.37e-06	1.86e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PTEN—malignant glioma	3.36e-06	1.86e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PIK3CD—malignant glioma	3.36e-06	1.86e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PIK3CD—malignant glioma	3.33e-06	1.84e-05	CbGpPWpGaD
Tamoxifen—CYP19A1—Metabolism—AKT1—malignant glioma	3.27e-06	1.81e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—KRAS—malignant glioma	3.26e-06	1.8e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PIK3CG—malignant glioma	3.24e-06	1.79e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PIK3CB—malignant glioma	3.18e-06	1.76e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—PIK3CA—malignant glioma	3.18e-06	1.76e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PTGS2—malignant glioma	3.16e-06	1.75e-05	CbGpPWpGaD
Tamoxifen—CYP1B1—Metabolism—AKT1—malignant glioma	3.15e-06	1.74e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PPARG—malignant glioma	3.13e-06	1.73e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PIK3CB—malignant glioma	3.11e-06	1.72e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PTEN—malignant glioma	3.08e-06	1.71e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PTGS2—malignant glioma	3.08e-06	1.71e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—PIK3CA—malignant glioma	2.99e-06	1.66e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PIK3CB—malignant glioma	2.93e-06	1.62e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PIK3CB—malignant glioma	2.9e-06	1.61e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PTGS2—malignant glioma	2.9e-06	1.61e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—TP53—malignant glioma	2.9e-06	1.6e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PTGS2—malignant glioma	2.88e-06	1.59e-05	CbGpPWpGaD
Tamoxifen—ABCG2—Metabolism—AKT1—malignant glioma	2.86e-06	1.59e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PIK3CD—malignant glioma	2.85e-06	1.58e-05	CbGpPWpGaD
Tamoxifen—CYP3A7—Metabolism—AKT1—malignant glioma	2.84e-06	1.57e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PTEN—malignant glioma	2.75e-06	1.52e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—CAV1—malignant glioma	2.74e-06	1.52e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PTEN—malignant glioma	2.69e-06	1.49e-05	CbGpPWpGaD
Tamoxifen—CYP2A6—Metabolism—AKT1—malignant glioma	2.6e-06	1.44e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—PIK3CA—malignant glioma	2.57e-06	1.42e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PTEN—malignant glioma	2.53e-06	1.4e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—PIK3CA—malignant glioma	2.52e-06	1.39e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—PIK3CA—malignant glioma	2.51e-06	1.39e-05	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PTEN—malignant glioma	2.51e-06	1.39e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PIK3CG—malignant glioma	2.5e-06	1.38e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PIK3CB—malignant glioma	2.48e-06	1.37e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PTGS2—malignant glioma	2.46e-06	1.36e-05	CbGpPWpGaD
Tamoxifen—ESR1—Signaling Pathways—AKT1—malignant glioma	2.45e-06	1.35e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PPARG—malignant glioma	2.41e-06	1.34e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—PIK3CA—malignant glioma	2.37e-06	1.31e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PIK3CD—malignant glioma	2.2e-06	1.22e-05	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—PIK3CA—malignant glioma	2.18e-06	1.2e-05	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PTEN—malignant glioma	2.14e-06	1.19e-05	CbGpPWpGaD
Tamoxifen—CYP2B6—Metabolism—AKT1—malignant glioma	2.1e-06	1.16e-05	CbGpPWpGaD
Tamoxifen—CYP2E1—Metabolism—AKT1—malignant glioma	2.06e-06	1.14e-05	CbGpPWpGaD
Tamoxifen—CYP3A5—Metabolism—AKT1—malignant glioma	2.05e-06	1.14e-05	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—PIK3CA—malignant glioma	1.94e-06	1.08e-05	CbGpPWpGaD
Tamoxifen—CYP1A1—Metabolism—AKT1—malignant glioma	1.94e-06	1.07e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.92e-06	1.06e-05	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PTGS2—malignant glioma	1.9e-06	1.05e-05	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—PIK3CA—malignant glioma	1.89e-06	1.05e-05	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—PIK3CA—malignant glioma	1.79e-06	9.89e-06	CbGpPWpGaD
Tamoxifen—CYP2C8—Metabolism—AKT1—malignant glioma	1.78e-06	9.84e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—PIK3CA—malignant glioma	1.77e-06	9.8e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PTEN—malignant glioma	1.65e-06	9.16e-06	CbGpPWpGaD
Tamoxifen—CYP2C19—Metabolism—AKT1—malignant glioma	1.59e-06	8.78e-06	CbGpPWpGaD
Tamoxifen—ABCB1—Metabolism—AKT1—malignant glioma	1.55e-06	8.57e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—PIK3CA—malignant glioma	1.51e-06	8.38e-06	CbGpPWpGaD
Tamoxifen—CYP2D6—Metabolism—AKT1—malignant glioma	1.46e-06	8.08e-06	CbGpPWpGaD
Tamoxifen—CYP2C9—Metabolism—AKT1—malignant glioma	1.45e-06	8.01e-06	CbGpPWpGaD
Tamoxifen—CYP1A2—Metabolism—AKT1—malignant glioma	1.24e-06	6.84e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.17e-06	6.46e-06	CbGpPWpGaD
Tamoxifen—CYP3A4—Metabolism—AKT1—malignant glioma	9.54e-07	5.28e-06	CbGpPWpGaD
